Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-04-29
1993-09-28
Ossanna, Nina
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 424 851, 530324, A61K 3702
Patent
active
052486664
ABSTRACT:
Novel polypeptide compositions are provided which inhibit human tumor cell growth, which may or may not stimulate autophosphorylation of pp6src and induce the release of a 52 kD polypeptide from neoplastic cells. Individual polypeptides may be isolated from mammalian blood platelets by selected extraction and purification procedures, may be synthesized or produced by hybrid DNA technology.
REFERENCES:
patent: 4529594 (1985-07-01), Hayashi et al.
patent: 4530901 (1985-07-01), Weissman
patent: 4543329 (1985-09-01), Daum et al.
patent: 4565785 (1986-01-01), Gilbert et al.
patent: 4582800 (1986-04-01), Crowl
patent: 4590003 (1986-05-01), Twardzik
patent: 5147854 (1992-09-01), Newman et al.
Monoclonal Antibody Targeting of Anti-Cancer Agents in "New Experimental Modalities in the Control of Neoplasia" Ed. by Chandra.
"Suramin Inhibits Human Osteosarcoma Xenografts in Nude Mice" Cancer Research Walz et al. 51 3585-3589, Jul. 1991.
M. Poncs, et al., Cloning & Characterization of Platelet Factor 4 cDNA derived from a Human Erythroleukemic Cell Line, Chemical Abstracts, 106(1987) p. 165.
F. J. Morgan, et al, Complete Covalent Structure of Human Platelet Factor 4, Thrombos Haemostas (Stuttg.) (1979) 42:1652-1660.
Chemical Abstracts, 87 (1977) p. 183.
L. L. Brindley et al, Stimulation of histamine release from human basophils by human platelet factor 4, (1983) 72:1218-1223.
H. G. Klingeman et al, Beta-Thromboglobulin and HA-platelet factor 4 in multiple myeloma, Hodgkin disease and malignant lymphoma-effects of therapy, Thromb. Haemostasis, (1981) 46:1: p. 430, abstract no. 1380.
V. Miggiano et al, Murine monoclonal antibodies against human beta-thromboglobulin (betaTG), Chemical Abstracts, (1982) 96:ref. no. 102116s.
J. W. Lawler, "Prediction of the secondary structure of platelet factor 4 and beta-thromboglobuoin from their amino acid sequences", Thrombosis Research, (1981) 21:121-127.
D. Paul et al., "Platelet basic protein: A mitogenic peptide for 3T3 cells secreted by human platelets", Chemical Abstracts, (1980) 93:11, p. 130 ref. no 107692z.
J. Folkman, "Angiogenesis: Initiation and modulation", Symp. Fund. Cancer Res., (1983) 36:201-208.
J. Folkman, "The role of heparin in angiogenesis", CIBA Found. Symp. (1983) 42:1652-1660.
M. Hermodson, et al., Isolation, Crystallization, and Primary Amino Acid Sequence of Human Platelet Factor 4, J. Biol. Chem, (1977) 252:6276-6279.
S. Taylor & J. Folkman, Protamine is an Inhibitor of Angiogenesis, Nature (1982) 297:307-312.
Chemical Abstracts, 103 (1985) p. 616.
Todaro George J.
Twardzik Daniel R.
Oncogen
Ossanna Nina
LandOfFree
Methods for inhibiting neoplastic cell proliferation using plate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting neoplastic cell proliferation using plate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting neoplastic cell proliferation using plate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2190926